Liesa Regner-Nelke

发表

Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapies.

H. Hartung, F. Zipp, S. Meuth, 2022, Multiple sclerosis and related disorders.

Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis

Michael D. Ernst, G. Nelles, T. Ziemssen, 2022, Neurological Research and Practice.

Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitis.

I. Amit, F. Rosenow, D. Esser, 2023, Journal of autoimmunity.

Enjoy Carefully: The Multifaceted Role of Vitamin E in Neuro-Nutrition

S. Meuth, T. Warnecke, T. Ruck, 2021, International journal of molecular sciences.

Eculizumab versus rituximab in generalised myasthenia gravis

H. Hartung, H. Wiendl, S. Meuth, 2022, Journal of Neurology, Neurosurgery, and Psychiatry.

Myositis in Germany: epidemiological insights over 15 years from 2005 to 2019

S. Meuth, M. Pawlitzki, T. Ruck, 2022, Neurological Research and Practice.

Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab

S. Meuth, T. Ruck, P. Albrecht, 2022, Frontiers in Immunology.

Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab

H. Hartung, S. Meuth, M. Barnett, 2022, Journal of Neurology, Neurosurgery, and Psychiatry.

Bilateral vocal cord palsy as complication of CNS tuberculosis

W. Schwindt, B. Labeit, S. Suntrup-Krueger, 2023, BMC Neurology.